A Study of Zigakibart in Adults With IgA Nephropathy
Clinical trial NCT05852938 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05852938
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-06
- Primary completion
- 2027-08-10
- Enrollment
- 383
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.